Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Robert Marcus
Oct 4, 2021

Related news

Feb 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Can tech for good be as profitable as plain old tech?

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Aug 11
,
0221
AI
Cleantech
Healthcare
Investment
Life Science
Press

Major venture capital investment in European life sciences will fuel occupier market

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Women less likely to win major research awards

Nov 29
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How AI Is Aiming at the Bad Math of Drug Development

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict massive growth in health tech

Dec 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analysts compile top European biotech news of 2021

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding